Search results
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 23 hours agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 1 day agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 21 hours agoImage source: The Motley Fool. Moderna (NASDAQ: MRNA) Q1 2024 Earnings Call May 02, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Analyst Report: Moderna, Inc.
Morningstar Research via Yahoo Finance· 16 hours agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 23 hours agoMuch of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo Finance· 1 day agoModerna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines was ...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 1 day agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 30 minutes agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 1 day agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 23 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...